Founded by genomic data engineers who helped build the UK’s national genomic medicine infrastructure. Now building the platform to bring precision medicine to the world.

Our Foundation

Forged in World-Class Genomics. Built for the World.

Genomatis was founded by engineers and scientists whose careers were shaped by some of the most ambitious genomic medicine programmes in the world — including the UK’s Genomic Medicine Service, where our founding team contributed to the data processing infrastructure behind the sequencing of over 100,000 genomes for rare disease and cancer patients.

That experience revealed a critical gap: while large-scale genomic medicine had been proven viable, the technology remained inaccessible to most of the world — locked behind prohibitive costs, slow turnaround times, and fragmented infrastructure.

Genomatis exists to close that gap. We took deep domain expertise in genomic data engineering and rebuilt the platform from the ground up — leveraging modern AI, cloud-native architecture, and scalable design to deliver clinical-grade genomic analysis at 2.6% of legacy costs for the analysis reports.

Today, our platform processes genomic data for hospitals, laboratories, government health programmes, and municipalities — bringing precision medicine to populations that have never had access to it before.

2018UK Genomic MedicineOur founders begin working on large-scale genomic data platforms within the UK’s national genomic medicine initiatives.
2021Expertise ProvenNational-scale genomic pipelines our team helped build go live, processing rare disease and cancer referrals for millions of patients in the UK.
2022Genomatis FoundedThe team sets out to democratise genomic medicine, starting with a complete new platform design using modern AI/ML.
2024Platform MaturityCore processing engine operational with AI-powered interpretation, achieving 99.7% variant classification precision.
2025Full Product SuiteFive integrated products launched, spanning clinical analysis, neonatal screening, population health, and municipal healthcare.
£700M+
UK Programme Our Team Contributed To
100K+
Genomes Our Expertise Helped Process
£85
Per Genome Analysis & Report
38x
Faster Than Legacy Systems

Our Mission

To make clinical-grade genomic medicine accessible to every healthcare system in the world — regardless of size, budget, or geography.

Our Values

01

Clinical Rigour

Every decision we make prioritises patient safety and diagnostic accuracy. We never compromise on clinical validation.

02

Radical Accessibility

Genomic medicine should not be a privilege of wealthy nations. We build for the world’s healthcare systems, not just the richest ones.

03

Transparent AI

Every AI-generated insight comes with a full evidence trail. Black boxes have no place in clinical genomics.

04

Scale by Design

Our architecture handles one genome or one million. We engineer for population-scale from day one.

Advancing Genomic Medicine, Together

Whether you are a hospital seeking better diagnostics, a government building a national programme, or a municipality transforming citizen healthcare — we have a solution designed for your scale.